Bristol-Myers's Melanoma Treatment Compares Favorably

Bristol-Myers Squibb said an analysis by an independent panel found that a study of its nivolumab treatment for melanoma compared favorably with another therapy.



from WSJ.com: US Business http://ift.tt/1pztEY7

via IFTTT